Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRABiotechnology
Healthcare
$0.33 -6.21%
-$0.10 today
- Market cap
- $62.85M
- Beta
- 2.76
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$1.24
52W Low $0.72High $3.65
Volume 1.79M
Average 2.02M
Price history
Neumora Therapeutics, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-87.42%
Period high
$3.59
Period low
$0.33
Latest
$0.33
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Oct 30, 2026 | Oct 30, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Jul 27, 2026 | Jul 27, 2026 | |
| 8-K | Jun 15, 2026 | Jun 15, 2026 | |
| 4 | May 29, 2026 | May 29, 2026 | |
| 4 | May 29, 2026 | May 29, 2026 | |
| 8-K | May 29, 2026 | May 29, 2026 | |
| 4 | May 29, 2026 | May 29, 2026 |
Competitors
Who does Neumora Therapeutics, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about NMRA's filings, answered from its disclosures.
What is the latest NMRA filing?
The latest filing shown is 8-K dated Oct 30, 2026.
How many recent filings does NMRA have?
Intrinsic Alpha currently shows 20 recent filings for NMRA.
Continue the stock analysis
Jump to another research area for this company.